CARDIO-PREVENT Trial

Study Overview

A randomized, double-blind study evaluating a novel antihypertensive medication for patients with moderate to severe hypertension. This study aims to assess the efficacy and safety of the investigational drug compared to standard treatment.

Inclusion Criteria

• ✓Adults aged 30-75 years
• ✓Diagnosed with hypertension for at least 6 months
• ✓Systolic blood pressure ≥140 mmHg
• ✓Willing to maintain current diet and exercise routine

Exclusion Criteria

• ✗History of heart failure
• ✗Severe kidney disease
• ✗Current pregnancy or planning to become pregnant
• ✗Participation in another clinical trial within 30 days